These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

951 related articles for article (PubMed ID: 10400906)

  • 1. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.
    Waltenberger J; Uecker A; Kroll J; Frank H; Mayr U; Bjorge JD; Fujita D; Gazit A; Hombach V; Levitzki A; Böhmer FD
    Circ Res; 1999 Jul; 85(1):12-22. PubMed ID: 10400906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Src tyrosine kinases in experimental pulmonary hypertension.
    Pullamsetti SS; Berghausen EM; Dabral S; Tretyn A; Butrous E; Savai R; Butrous G; Dahal BK; Brandes RP; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Rosenkranz S; Schermuly RT
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1354-65. PubMed ID: 22516066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indolocarbazoles: potent and selective inhibitors of platelet-derived growth factor receptor autophosphorylation.
    Spacey GD; Uings IJ; Slater M; Hirst S; Bonser RW
    Biochem Pharmacol; 1998 Feb; 55(3):261-71. PubMed ID: 9484791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spleen tyrosine kinase participates in Src-mediated migration and proliferation by PDGF-BB in rat aortic smooth muscle cells.
    Lee HM; Kim HJ; Park HJ; Won KJ; Kim J; Shin HS; Park PJ; Kim HJ; Lee KY; Park SH; Lee CK; Kim B
    Arch Pharm Res; 2007 Jun; 30(6):761-9. PubMed ID: 17679556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
    Panek RL; Lu GH; Klutchko SR; Batley BL; Dahring TK; Hamby JM; Hallak H; Doherty AM; Keiser JA
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.
    Kovalenko M; Gazit A; Böhmer A; Rorsman C; Rönnstrand L; Heldin CH; Waltenberger J; Böhmer FD; Levitzki A
    Cancer Res; 1994 Dec; 54(23):6106-14. PubMed ID: 7954456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine kinase activity of purified recombinant cytoplasmic domain of platelet-derived growth factor beta-receptor (beta-PDGFR) and discovery of a novel inhibitor of receptor tyrosine kinases.
    Zaman GJ; Vink PM; van den Doelen AA; Veeneman GH; Theunissen HJ
    Biochem Pharmacol; 1999 Jan; 57(1):57-64. PubMed ID: 9920285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration.
    Weber DS; Taniyama Y; Rocic P; Seshiah PN; Dechert MA; Gerthoffer WT; Griendling KK
    Circ Res; 2004 May; 94(9):1219-26. PubMed ID: 15059930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived growth factor-BB (PDGF-BB) regulation of migration and focal adhesion kinase phosphorylation in rabbit aortic vascular smooth muscle cells: roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinases.
    Cospedal R; Abedi H; Zachary I
    Cardiovasc Res; 1999 Mar; 41(3):708-21. PubMed ID: 10435043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal adhesion kinase facilitates platelet-derived growth factor-BB-stimulated ERK2 activation required for chemotaxis migration of vascular smooth muscle cells.
    Hauck CR; Hsia DA; Schlaepfer DD
    J Biol Chem; 2000 Dec; 275(52):41092-9. PubMed ID: 10998418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-independent trans-activation of the platelet-derived growth factor receptor by reactive oxygen species requires protein kinase C-delta and c-Src.
    Saito S; Frank GD; Mifune M; Ohba M; Utsunomiya H; Motley ED; Inagami T; Eguchi S
    J Biol Chem; 2002 Nov; 277(47):44695-700. PubMed ID: 12226102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration.
    Pukac L; Huangpu J; Karnovsky MJ
    Exp Cell Res; 1998 Aug; 242(2):548-60. PubMed ID: 9683541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of herbimycin A on tyrosine kinase receptors and platelet derived growth factor (PDGF)-induced signal transduction.
    Murakami Y; Fukazawa H; Mizuno S; Uehara Y
    Biol Pharm Bull; 1998 Oct; 21(10):1030-5. PubMed ID: 9821805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor.
    Dahring TK; Lu GH; Hamby JM; Batley BL; Kraker AJ; Panek RL
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1446-56. PubMed ID: 9190882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
    J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Src mediates mitogenic signals and associates with cytoskeletal proteins upon vascular endothelial growth factor stimulation in Kaposi's sarcoma cells.
    Munshi N; Groopman JE; Gill PS; Ganju RK
    J Immunol; 2000 Feb; 164(3):1169-74. PubMed ID: 10640727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of a Src phosphorylation site in the PDGF beta-receptor leads to increased PDGF-stimulated chemotaxis but decreased mitogenesis.
    Hansen K; Johnell M; Siegbahn A; Rorsman C; Engström U; Wernstedt C; Heldin CH; Rönnstrand L
    EMBO J; 1996 Oct; 15(19):5299-313. PubMed ID: 8895575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of mitogen-activated protein kinase activation within focal adhesions in chemotaxis toward FGF-2 by murine brain capillary endothelial cells.
    Shono T; Kanetake H; Kanda S
    Exp Cell Res; 2001 Apr; 264(2):275-83. PubMed ID: 11262184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of platelet-derived growth factor receptor tyrosine kinase inhibits vascular smooth muscle cell migration and proliferation.
    Myllärniemi M; Calderon L; Lemström K; Buchdunger E; Häyry P
    FASEB J; 1997 Nov; 11(13):1119-26. PubMed ID: 9367346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.